AstraZeneca Obtains Approval For Pulmicort Inhaler Pediatric Use In Japan
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare cleared AstraZeneca's Pulmicort Turbuhaler (budesonide) for pediatric use